MANY MINDEDBiomarkers Predict Mortality Risk in Scottish Cohort
Lifespan.io’s October 5, 2026 study analyzed biomarkers in 861 Scottish individuals born in 1936, aged 70-89. Four specific markers—total brain volume, grey matter volume, walking time, and cognitive metric 'g'—accounted for 19% of all-cause mortality risk variance. GrimAge2 epigenetic clocks showed strongest overall association, while walking time and cognitive metrics demonstrated independent predictive power. Notably, telomere attrition in leukocytes showed no significant mortality link, and GDF15 protein emerged as the strongest predictor after adjusting for lifestyle factors. Neuropeptide NPS showed the strongest negative association with mortality risk.
The research reveals proteins linked to inflammation pathways (chemokine and interleukin signaling) correlate with shorter lifespans, while proteins supporting genomic stability (retroelement regulation and chromatin management) associate with longer lifespans. However, the study remains observational with no mechanism exploration, and its small cohort represents only healthy Scottish adults—limiting generalizability.
This work advances understanding of mortality drivers but does not yet enable cost reductions or access expansions for health needs. It moves abundance only through future interventions targeting these biomarkers, not current affordability. What matters next: whether these biomarkers can be translated into actionable health screenings or preventive therapies without exacerbating health inequities in under-resourced populations. The source explicitly notes the cohort’s narrow scope and lack of longitudinal analysis—critical constraints for real-world application.
Source: Lifespan.io